Glycine receptors in the nucleus accumbens involved in the ethanol intake-reducing effect of acamprosate.

Alcohol Clin Exp Res

Addiction Biology Unit, Section of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Sweden.

Published: January 2010

Background: We have previously demonstrated that strychnine-sensitive glycine receptors (GlyRs) in the nucleus accumbens (nAc) and nicotinic acetylcholine receptors (nAChRs) in the ventral tegmental area are involved in mediating ethanol (EtOH)-induced elevation of dopamine in the rat mesolimbic dopamine system. This neuronal circuitry was also demonstrated to mediate dopamine elevation in the nAc after both taurine, an endogenous agonist of GlyRs, and acamprosate, a synthetic derivate of homotaurine. The aim of this study was to investigate whether the EtOH intake-reducing effect of acamprosate involves accumbal GlyRs.

Methods: For this purpose, we used a voluntary EtOH consumption model where EtOH medium- and high-preferring rats were implanted with guide cannulae in the nAc. The animals received daily injections of acamprosate or 0.9% NaCl before accessing a bottle of 6% EtOH and a bottle of water. After 2 days, a microinjection of strychnine or vehicle preceded the daily systemic injection and bottle-access period.

Results: Acamprosate, but not saline, decreased EtOH intake. Pretreatment with Ringer in the nAc did not influence EtOH intake in saline or acamprosate-treated animals. Pretreatment with strychnine had no effect on EtOH intake in saline-treated animals, whereas it completely reversed the EtOH intake-reducing effect of acamprosate.

Conclusions: Based on current and previous results, we suggest that acamprosate primarily interacts with accumbal GlyRs and secondarily with ventral tegmental nAChRs, in a similar manner to that previously observed with EtOH and taurine. The interaction between acamprosate and GlyRs does not only influence dopamine output in the nAc but also EtOH consumption, giving further support for our hypothesis that GlyRs are of importance in EtOH reinforcement.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1530-0277.2009.01063.xDOI Listing

Publication Analysis

Top Keywords

etoh intake
12
etoh
11
glycine receptors
8
nucleus accumbens
8
intake-reducing acamprosate
8
ventral tegmental
8
etoh intake-reducing
8
etoh consumption
8
acamprosate
7
glyrs
5

Similar Publications

Background & Aims: Expression of P21, encoded by the gene, has been associated with fibrosis progression in steatotic liver disease (SLD); however, the underlying mechanisms remain unknown. In the present study, we investigated the function of CDKN1A in SLD.

Methods: expression levels were evaluated in different patient cohorts with SLD, fibrosis, and advanced chronic liver disease (ACLD).

View Article and Find Full Text PDF

Oleanolic acid protects ethanol-induced memory impairments.

Behav Brain Res

March 2025

Department of Korean Internal Medicine, College of Korean Medicine, Sang-Ji University, 3 Sangjidae-gil, Wonju-si, Gangwon-do 26339, Republic of Korea. Electronic address:

Article Synopsis
  • * Ethanol affects GABA receptors, leading to changes in neurotransmission that could result in memory loss and increase the likelihood of psychiatric disorders like dementia.
  • * Oleanolic acid (OA) was found to protect against ethanol-induced memory impairment by blocking alterations in N-methyl-D-aspartate receptor function, suggesting its potential as a treatment for overcoming Ethanol-related cognitive issues.
View Article and Find Full Text PDF

Chronic alcohol-related myopathy: a closer look at the role of lipids.

Front Physiol

November 2024

Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, United States.

Article Synopsis
  • Chronic alcohol-related myopathy (CAM) is a condition that results in muscle weakness and atrophy due to long-term excessive alcohol consumption.
  • The mechanisms behind how alcohol causes muscle loss are not fully understood, but this article explores how changes in lipid profiles may play a significant role.
  • The authors review existing studies on lipid changes in individuals with CAM and suggest that disrupted lipid regulation could be a key factor in the muscle wasting linked to alcohol use, proposing new directions for research and treatment.
View Article and Find Full Text PDF

Objective: To examine the efficacy and safety of sodium oxybate versus placebo in a phase IIb randomized double-blind placebo-controlled 2-period cross-over clinical trial in patients with isolated laryngeal dystonia (LD).

Methods: The study was conducted from January 2018 to December 2021, pausing during the COVID-19 pandemic, at Massachusetts Eye and Ear in 106 patients with alcohol-responsive (EtOH+) and alcohol-non-responsive (EtOH-) LD (53 to receive 1.5g of sodium oxybate first, 53 to receive matching placebo first).

View Article and Find Full Text PDF

Genome wide association and animal studies have implicated genetic variations in CHRNΑ5, encoding the α5 subunit-containing nicotinic acetylcholine receptors (α5*nAChRs), as a risk factor for developing alcohol use disorders (AUDs). To understand how α5*nAChR mutations may influence alcohol (EtOH) drinking behavior, we used a two-bottle choice procedure with intermittent access to alcohol in male and female transgenic mice expressing either the highly frequent human single nucleotide polymorphism (α5SNP/rs16969968) or a deletion of the Chrna5 gene (α5KO). AUDs-related preconsommatory traits (anxiety, sensation-seeking and impulsivity) were assessed with a battery of relevant tasks (elevated-plus maze, novel place preference and step-down inhibitory avoidance).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!